Krystal Biotech Stock Gains on Earnings Optimism
Krystal Biotech's earnings revisions signal further stock upside amid analyst optimism and strong Zacks Rank.
- Latest
- Trending
Krystal Biotech's earnings revisions signal further stock upside amid analyst optimism and strong Zacks Rank.
CleanSpark's shares fall as August Bitcoin mining output drops. Future expansion planned with new data center capacity.
GitLab raises annual guidance after Q2 results surpass estimates, driven by margin expansion and robust deal activity.
September brings challenges for Bitcoin with historical trends, Fed moves, and election impacts influencing crypto markets.
Ethereum ETFs see no activity, Bitcoin ETFs face significant outflows. Bitcoin down 9% and Ethereum drops 22% in August.
Hospitals see revenue growth in July, but rising costs threaten future stability, according to Strata Decision Technology report.
Bitcoin's rise to $100,000 by year's end is plausible due to historical trends and potential interest rate cuts.
Bitcoin sees sharp decline, influenced by technical resistance and market reactions to Nvidia's earnings.
Citi cites increased costs of H200 GPUs affecting Nvidia's margins, impacting stock despite positive quarterly results.
Okta boosts annual guidance after Q2 results beat estimates, driven by new business gains, lifting shares by over 4%.
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.